Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INSMED Inc Director's Dealing 2019

Jun 10, 2019

30150_dirs_2019-06-10_4b624059-0379-45f0-9397-60cc5d2d8e8a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2019-06-06

Reporting Person: Schaeffer Orlov S Nicole (Chief People Strategy Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-06-06 Stock Option M 12000 $6.96 Acquired 36350 Direct
2019-06-06 Stock Option S 12000 $23.2366 Disposed 24350 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-06-06 Stock Option (right to buy) $6.96 M 12000 Disposed 2023-01-02 Common Stock (12000) Direct

Footnotes

F1: This is the weighted average sales price representing 12,000 shares sold at prices ranging from $23.00 to $23.66 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.

F2: Stock options granted under the Company's 2000 Incentive Plan. These stock options are currently exercisable.